Mycobacterial genomic DNA from used Xpert MTB/RIF cartridges can be utilised for accurate second-line genotypic drug susceptibility testing and spoligotyping

Scientific Reports
Rouxjeane VenterGrant Theron

Abstract

Xpert MTB/RIF (Xpert) is a widely-used test for tuberculosis (TB) and rifampicin-resistance. Second-line drug susceptibility testing (DST), which is recommended by policymakers, typically requires additional specimen collection that delays effective treatment initiation. We examined whether cartridge extract (CE) from used Xpert TB-positive cartridges was, without downstream DNA extraction or purification, suitable for both genotypic DST (MTBDRplus, MTBDRsl), which may permit patients to rapidly receive a XDR-TB diagnosis from a single specimen, and spoligotyping, which could facilitate routine genotyping. To determine the limit-of-detection and diagnostic accuracy, CEs from dilution series of drug-susceptible and -resistant bacilli were tested (MTBDRplus, MTBDRsl). Xpert TB-positive patient sputa CEs (n = 85) were tested (56 Xpert-rifampicin-susceptible, MTBDRplus and MTBDRsl; 29 Xpert-rifampicin-resistant, MTBDRsl). Spoligotyping was done on CEs from dilution series and patient sputa (n = 10). MTBDRplus had high non-valid result rates. MTBDRsl on CEs from dilutions ≥103CFU/ml (CT ≤ 24, >"low" Xpert semiquantitation category) was accurate, had low indeterminate rates and, on CE from sputa, highly concordant with MTBDRsl isolat...Continue Reading

References

Oct 27, 2006·Journal of Clinical Microbiology·E M StreicherR M Warren
May 28, 2010·Journal of Clinical Microbiology·Robert BlakemoreDavid Alland
Aug 20, 2010·Journal of Clinical Microbiology·Padmapriya P BanadaDavid Alland
Sep 10, 2010·The New England Journal of Medicine·Catharina C BoehmeMark D Perkins
Mar 1, 2012·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Christophe DemayNalin Rastogi
Oct 24, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Karen R JacobsonRobin M Warren
Mar 23, 2013·The European Respiratory Journal·Jonathan G PeterKeertan Dheda
Mar 29, 2014·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·H CoxG van Cutsem
Aug 19, 2014·BMC Infectious Diseases·Nomonde R Dlamini-MvelaseKoleka P Mlisana
Dec 17, 2014·Tropical Medicine & International Health : TM & IH·Nora EngelMadhukar Pai
May 16, 2015·Tropical Medicine & International Health : TM & IH·Helen CoxEdina Sinanovic
Feb 26, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Grant TheronKeertan Dheda
Jun 12, 2016·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·J Z MetcalfeP C Hopewell
Sep 9, 2016·The Cochrane Database of Systematic Reviews·Grant TheronKaren R Steingart
Oct 4, 2016·Public Health Action·B N Sharath, S Shastri
Jan 20, 2017·The European Respiratory Journal·Ruvandhi R NathavitharanaClaudia M Denkinger
Sep 13, 2017·Antimicrobial Agents and Chemotherapy·John Z MetcalfeDavid M Engelthaler
Oct 12, 2017·Critical Reviews in Clinical Laboratory Sciences·Khosrow AdeliNicole White-Al Habeeb

❮ Previous
Next ❯

Methods Mentioned

BETA
nucleic acid amplification
genotyping
PCR

Software Mentioned

Xpert

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Related Papers

The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
Annelies Van RieRobin M Warren
Lancet
Fulvio SalvoDaniela Maria Cirillo
Lancet
Giovanni FerraraMarkus Maeurer
© 2022 Meta ULC. All rights reserved